MoonLake Immunotherapeuti... (MLTX)
undefined
undefined%
At close: undefined
51.34
-0.10%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue - - - -
Cost of Revenue 13.16K 12.36K 4.97K -
Gross Profit -13.16K -12.36K -4.97K -
Operating Income -54.12M -65.06M -53.58M -105.76K
Interest Income - - - 14.92K
Pretax Income -43.98M -64.47M -53.64M -90.84K
Net Income -36.01M -64.51M -53.64M -90.84K
Selling & General & Admin 22.32M 23.01M 18.05M 105.75K
Research & Development 31.80M 42.05M 35.52M -
Other Expenses - 591.73K - -
Operating Expenses 54.12M 65.06M 53.57M 105.75K
Interest Expense - - - -
Selling & Marketing Expenses - - 18.03M -
Cost & Expenses 54.12M 65.06M 53.58M 105.75K
Income Tax 94.39K 36.37K 4.75K -206.30K
Shares Outstanding (Basic) 49.12M 29.36M 7.84M 14.80M
Shares Outstanding (Diluted) 49.12M 29.36M 7.84M 14.80M
EPS (Basic) -0.73 -2.2 -6.84 -0.01
EPS (Diluted) -0.73 -2.2 -6.84 -0.01
EBITDA -54.11M -65.05M -53.63M -90.84K
Depreciation & Amortization 13.16K 12.36K 4.97K 206.30K